Background/Objective: Medication reconciliation at transitions of care decreases medication errors, hospitalizations, and adverse drug events. We compared inpatient medication histories and reconciliation across disciplines and evaluated the nature of discrepancies.
O btaining medication histories and conducting medication reconciliation are challeng ing tasks with the advent of new molecular entities and orphan drugs. 1 As Franklin reported, "Patients who once came into the [physician] offi ce carrying their medications in a purse, or pocket, now need a shopping bag." 2 The importance of accurate medication histories cannot be overemphasized; nearly 27% of all hospital prescribing errors originate from incorrect admission medication histories, over 70% of drug-related problems are only discovered through patient interview, and more than 50% of discharge discrepancies are associated with admission discrepancies. [3] [4] [5] [6] Supplementary material: The online version of this article (doi: 10.1310/hpj4909-826) contains the eAppendix, which includes eFigures 1 and 2 and eTables 1-4. In 2010, an Institute of Medicine report estimated that if hospitals prevented adverse drug events (pADEs) and redundant tests, the associated cost savings would be nearly $25 billion annually. 7 One organization decreased inpatient care costs by 30% when no medication reconciliation errors were reported over 24 months. 7 Multiple organizations have supported medication reconciliation to improve quality of care, reduce preventable hospital admissions and readmissions, and decrease the incidence of adverse health careassociated conditions. [8] [9] [10] [11] Although The Joint Commission does not indicate the discipline to perform this role, evidence supports the role of registered pharmacists (RPhs), pharmacy students, and pharmacy technicians in collecting accurate medication histories. RPhs should be involved when high-risk medications are identifi ed, more than 5 medications are reported, or patients are elderly. 6, 8, Therefore, our primary study objective was to compare inpatient medication histories and reconciliation processes across disciplines and to evaluate the nature of discrepancies using a novel method.
METHODS

Study Design, Setting, and Participants
A prospective cohort study design was conducted in the Wesley Medical Center 760-bed acute care hospital from February 15, 2010 to April 11, 2010 . Eligible patients were consented approximately 18 to 24 hours after being admitted to the hospital from the emergency department. Patients were excluded if they were direct hospital admissions or were readmitted to the hospital during the study period. The Wichita Medical Research and Education Foundation Institutional Review Board approved the study and required patient informed consent.
Medication History and Medication Reconciliation Initiation
Iatric (version 2.5.151; Iatric Systems, Inc., Boxford, MA) and Meditech (version 5.6.3; MEDI-TECH, Westwood, MA) software was used for the medication history and reconciliation process. Participants had admission medication histories taken 3 times: fi rst, by the admitting hospital unit nurse (RN), then by a certifi ed pharmacy technician (CPhT), and fi nally by an RPh (Figure 1) . In a previous medication history study at our institution, RNs altered their process when pharmacists were involved; therefore, RNs were blinded to the study protocol. 41 CPhTs and RPhs were not blinded to the study protocol. CPhTs telephoned pharmacies and physician offi ces to request faxed medication lists for review. However, they did not discuss these medication lists, because this has been deemed not permissible by some pharmacy boards. 42 Changes to the medication and allergy history could be made electronically by the RN or RPh; the documented history and changes were accessible to the investigators by audit report. Adverse drug reactions (ADRs) and medication errors were reported per hospital policy. The discharge medication reconciliation process was completed according to hospital policy, such that RNs completed the participant discharge medication list with a second RN verifying the list.
Primary Outcome: Medication Discrepancies
Medication discrepancies were identifi ed by comparing medication histories and interventions documented by the RN, CPhT, and RPh to each other and to the physician's home medication orders on admission. Discrepancies were classifi ed using the Medication Discrepancy Tool (MDT) developed by Smith and colleagues, 43 which addresses causes and contributing factors at both the patient and system levels. A discrepancy enumeration worksheet was used to capture the discipline committing the discrepancy, the discrepancy category (extra, omitted, duplicate, incomplete, incorrect) and drug data dictionary noncompliance (explanation below), the attribute (medication, dose, route, frequency), occurrence (admit, discharge), drug involved, resolution (fi xed, not fi xed), discipline resolving the discrepancy, and whether the computer system was involved.
Drug dictionary discrepancies occurred when medications were typed as free text rather than selected using the drug data dictionary, which categorized and sorted medications in the appropriate American Hospital Formulary Service (AHFS) pharmacologictherapeutic classifi cation system. 44 Free-text medications appeared in a separate section at the bottom of the discharge medication reconciliation report, potentially allowing medications to be selected from duplicate drug classes, that is, an unclassifi ed home medication (typed as free text) and an AHFS classifi ed hospital administered medication (from the drug data dictionary). Unresolved admission discrepancies were counted at discharge if the provider selected the medication containing the discrepancy for the participant discharge list. Thus, we tracked the number and type of discrepancies that occurred from the beginning through the end of participant hospitalization.
Other Variables
Participant characteristics included sex, age range, body mass index (BMI), reason for admission, concomitant disease state(s), principle diagnosis, length of stay, and 30-and 90-day readmission rates. Number and type of medications (ie, prescription medications, over-the-counter products, herbals) at admission and discharge, medication discrepancies, prevented medication discrepancies, ADRs, pADEs, and core measures falling out of compliance were tabulated. pADEs were defi ned as those discrepancies committed on admission by the RN that were avoided because of RPh intervention. To be included as pADEs, discrepancies were required to have a severity ranking of 5 or greater and a detection ranking of 5 or greater (see method for calculating below). Information obtained during the medication reconciliation process included number of pharmacies used by participants, number of faxes obtained and phone calls required, and the method for home medication reconciliation.
Calculations for Evaluating Discrepancies
The unit of analysis for comparing discrepancies among the 3 disciplines (RN, CPhT, and RPh) was the medication discrepancy rate, defi ned as the number of discrepancies per number of medications. To assign a score to each discrepancy, a failure mode effect and criticality analysis (FMECA) was conducted using Williams and Talley defi nitions. 45 The criticality index (CrI) for each failure (discrepancy) was calculated using the following equation: CrI = sample occurrence frequency x effect severity x detection probability where FMECA rankings were fi nite numbers per Williams and Talley defi nitions 45 : occurrence frequency = 1 through 10, effect severity = 1 through 9, and detection probability = 1 through 9 ( Table 1) . Detection probability was subjective because identifi cation of the discrepancy had to occur by the pharmacist reviewer. A novel method of computer programming, the Discrepancy Rating System (DRS), was developed to systematically evaluate the impact of discrepancies as calculated by the CrI for each discrepancy committed or avoided. First, a search of the discrepancy database was completed to determine the FMECA occurrence frequency ranking. Each discrepancy was assigned an occurrence rating by categorizing all discrepancies by discipline, admit/discharge, drug class, and fi xed/not fi xed. For each discrepancy, the sum of all other discrepancies matching it in every Low, low likelihood that error will be detected before product/service reaches patient; 2 of 10 and 1 of 10
Omitted medication. Extra medication, Extra dose, Extra frequency.
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Remote, detection not possible at any point within system; 0 of 10 9 Note: AHFS = American Hospital Formulary Service.
category was taken and distributed over the entire 718 patient-day study period. The rate (discrepancy of this type per patient-day) was then used to assign an occurrence rating for discrepancy. Next, the FMECA effect severity ranking was determined by 3 blinded clinical RPhs with medication safety training at our institution using AHFS classifi cation. Finally, the same 3 blinded clinical RPhs determined detection probability ranking by discrepancy type and attribute. Once values were assigned, the discrepancy database was programmed to calculate a CrI for admission and discharge discrepancies, both committed and avoided. CrI scores (CrIS) were tabulated and labeled as positive when discrepancies reached the participant, whereas discrepancies avoided were negative. To calculate the mean CrIS per participant by discipline, CrIS were summed and divided by number of discrepancies, such that where j = disciplines, n = participants, and d = number of discrepancies. Thus, at admission, each participant had 6 mean CrIS (3 negative and 3 positive) and 4 mean CrIS at discharge (2 negative and 2 positive). Because participants took various numbers of medications, a weighted criticality index (CrIS w ) was calculated in order to assign an overall admission score to each participant that represented the severity of medication errors by discipline:
where w = total number of medications prescribed at admission.
Statistical Analysis
A power analysis indicated that 144 patients would be suffi cient to detect a 30% discrepancy rate between disciplines, with 80% power and a 5% signifi cance level. This analysis was based on our previously published medication reconciliation study 41 where 30% represents the difference from a 70% accuracy rating for RPhs versus a 40% rating for RNs.
Descriptive statistics were conducted to summarize all variables. Participant characteristics were compared by sex using 2-sample proportions z test, t tests for continuous variables, and chi-square tests for categorical variables. Number of discrepancies per discipline was summarized by drug class and type for both admission and discharge. Discipline groups included in the admission reconciliation process were RN, CPhT, and RPh, whereas disciplines for discharge were RN and RPh. Admission corrections were also summarized by drug class and discipline.
A reliability analysis was conducted to compare medication discrepancy rates among disciplines. Both Cronbach's alpha and intraclass correlation coeffi cients (ICCs) were reported. Cronbach's alpha measured reliability, whereas ICCs assessed agreement between the disciplines. Both single and average ICCs were calculated using 2-way mixed effects models with absolute agreement. The model assumed the Table 1 . Failure mode effect and criticality analysis (FMECA) attributes (CONT.) disciplines were fi xed factors and discrepancy rates were random effects. A fi xed rater effect was chosen, because it does not allow fi ndings to be generalized to other raters and because raters were not randomly selected. Absolute agreement measured the extent to which disciplines were assigned the same absolute score and assumed that systematic variability due to the discipline was relevant. Single measures of reliability were those in which the individual scores constituted the unit of analysis and gave reliability of a single discipline's score, and they were used to assess whether the scores of one discipline were apt to be the same as for another discipline (ie, RNs vs CPhTs). Average measures of reliability assessed the stability of the mean score. Interpretation of analysis results were based on ICC 0.40 or less, poor to fair agreement; 0.41 to 0.60, moderate agreement; 0.61 to 0.80, good agreement; and 0.81 to 1.00, excellent agreement. To compare rates between disciplines, 2-sample proportion z tests were conducted. Because multiple tests were conducted, the Bonferroni correction method was used to determine statistical signifi cance. Similarly to above, 2 additional reliability analyses were conducted to evaluate discipline agreement on both negative and positive CrIS w . For these, Hotelling's T 2 was used to assess the extent to which CrIS w (negative or positive) agreed among disciplines. Finally, to evaluate the extent to which medication discrepancies may have infl uenced patient readmission, the association between admission discrepancy rates and readmission status was examined at 30 and 90 days post discharge. Statistical analyses were conducted using IBM SPSS Statistics (version 20; IBM Corp., Armonk, NY).
RESULTS
A total of 153 consented participants were evaluated in this prospective cohort study (Figure 2) . Participant characteristics by sex are summarized in Table 2 . There were signifi cantly more females than males (90 of 153 [58.8%]; z = 3.087, P = .002). Whereas there were no signifi cant differences for mean BMI between males and females, examination with standard groupings revealed there were significantly more females within a BMI category of 24.9 or less (36 of 84 [42.9%]; χ 2 = 12.6, P = .006). Distribution of principle diagnosis is represented in eFigure 1. Nearly 18% of participants had some type of respiratory disease, followed by circulatory and digestive disorders (13.7% each). The quantity of total medications per participant increased at discharge, with a median of 7 (mean 8.59, SD 5.97) at admission compared to 8 (mean 9.41, SD 5.78) at discharge ( Table 3) .
Discrepancies and Reliability Agreement Between Disciplines
The total number of discrepancies at admission across all disciplines (RN, CPhT, and RPh) was 1,461 and at discharge was 369 (RN and RPh) (eTable 1). The majority of discrepancies occurred for RNs at admission and discharge (777 [53.2%] and 207 [56.1%], respectively); of those, Analgesics and Antipyretics/Anorexigenic Agents and Respiratory and Cerebral Stimulants had the most frequently reported discrepancies. The number of corrected admission discrepancies was 1,102. RPhs had the most correction occurrences (977 [88.7%]) at admission. Similar Across all disciplines, the majority of discrepancies were categorized as either omitted or incorrect ( Table 4 ). Of the 777 total discrepancies reported for RNs, 405 (52.1%) were omitted and 204 (26.3%) were incorrect. Overall discrepancy rate occurrence per medication was signifi cantly higher for RNs compared with CPhTs (0.59 vs 0.36, respectively; P < .001) (average number of discrepancies per participant, 5.08 vs 3.10). At admission, RPhs corrected 469 of 1,102 (42.6%) omitted discrepancies. A substantial reduction in the number of all discrepancy types occurred at discharge compared to admission.
Criticality Index Assessment
Using CrI scores and the ICC criterion from above, both single and average ICC were poor agreement, with 0.16 and 0.37, respectively; Cronbach's alpha was 0.45. Evaluation of agreement for CrIS w scores among disciplines is shown in Table 5 . Results from reliability analyses for negative scores (discrepancies avoided) and positive scores (discrepancies reaching the participant) are displayed. Cronbach's alpha revealed poor reliability when evaluating among negative scores (α = 0.36), whereas α = 0.80 for positive scores. Higher scores, both negative and positive, indicated more severe discrepancies committed by the discipline that required resolution; negative scores were ultimately resolved. The lowest measures of agreement occurred for single measures on the negative scores (ICC = 0.14), indicating that scores had poor agreement among disciplines, and on average measures (ICC = 0.32), indicating that scores had poor stability. Improved agreement was observed for positive scores. Admission CrI percent reduction by discrepancy type and attribute for RN discrepancies corrected by the RPh is reported in eTable 2. The average CrI reduction was 79.0% with RPh involvement, preventing discrepancies from reaching participants.
Medication Reconciliation and pADE Cost Savings
A total of 120 (78.4%) participants had admission discrepancies that were identifi ed and fi xed (negative CrI score) by the RPh. Using the cost-benefi t ratio of $23.8:1, 46 assuming a mean time of 20 minutes per participant for an RPh-conducted medication history and reconciliation 17 and an RPh salary of $50 per hour, each RPh participant intervention would result in a cost avoidance of $397 per participant for a total cost savings of $47,640. There were 262 pADEs in 96 participants: 1 pADE (n = 31), 2 pADEs (n = 23), 3 pADEs (n = 17), 4 pADEs (n = 9), 5 pADEs (n = 9), 6 pADEs (n = 3), 7 pADEs (n = 2), 10 pADEs (n = 1), and 11 pADEs (n = 1). Number of admission pADEs classifi ed by AHFS, discrepancy type, and attribute is represented in Figure 3 . Assuming an ADE cost of $2,378 per event, 27 a conservative value, and excluding 14 pADE occurrences of the same drug and patient (ie, an incorrect drug dose and frequency), the total pADE-related cost savings was $589,744.
Adverse Drug Reactions and Medication Errors
Five (3.3%) study participants were admitted to the hospital because of documented adverse drug reactions (ADRs). There were no ADRs during Table 4 . Frequencies and rates for discrepancies and discrepancy corrections by type, hospital status, and discipline 
Core Measure Interventions
RPhs intervened 12 times in 10 participants to meet core measures: 2 stroke interventions in 2 participants, 6 deep vein thrombosis prophylaxis 
Readmission Results
The association between admission discrepancy rates and readmission status at 90 days for 135 participants is shown in eFigure 2. Evaluation at 30 days is not shown, because data were sparse and few readmissions had occurred. RN discrepancy rates, compared to all other disciplines, were more pronounced in the 2 or more readmissions category; however, data were sparse and 4 participants had 2 or more readmissions during this period.
DISCUSSION
Our study results indicate that CPhTs and RPhs prevented more discrepancies and committed less severe discrepancies than RNs. One possible explanation for these fi ndings could be the dedicated time that both CPhTs and RPhs had to perform medication histories, whereas RNs are frequently required to multitask. Ophir and colleagues 47 reported that people who multitask are more distracted compared to those who infrequently multitask. Another explanation may be that CPhTs received specialized training concerning what questions to ask when obtaining participant medication histories and were encouraged to call pharmacies and physician offi ces to have medication lists faxed when participants were unsure of their medications. CPhTs work with medications routinely; both CPhTs had retail pharmacy backgrounds and may have been more familiar with over-thecounter products and herbal supplements than RNs. Indeed, CPhTs had the lowest positive CrIS w admission scores; no data dictionary discrepancies were attributed to this discipline. Finally, CPhTs and RPhs may have had an advantage in that participants had additional time after admission to recall their medication history due to the order and timing of the intervention by discipline. It is unknown whether reversing the timing of the intervention (ie, CPhT or RPh completing the medication history fi rst) or providing RNs and CPhTs with the same access to medication information would have caused the results to differ. Regardless, because RNs were blinded, they had the same opportunity to verify the medication history and perform clarifi cations. In all, RNs corrected a total of 6 RN admission discrepancies (eTable 2).
This study presented a novel DRS using FMECA attributes to develop a CrIS w to measure the magnitude and severity of medication discrepancies. This system, when used as outlined in the Methods section, could monitor potential and committed medication errors for continuous quality improvement programs in the hospital setting. For example, use of a CrIS w paired with CPhT and RPh involvement targeting high-risk patient populations could quantitatively demonstrate a reduction in medication history and reconciliation errors. Moreover, implementing the DRS to improve the medication reconciliation process could potentially decrease the need for patient readmissions associated with medication errors at discharge. Systems of evaluating medication discrepancies using FMECA attributes may be helpful to other institutions that wish to consistently measure discrepancies, although these institutions may apply different ranking assignments to severity, detection, and occurrence. Therefore, future research is needed to evaluate discrepancies by discipline using a DRS.
This study had several limitations. First, it was originally proposed as a 2-phase project. However, phase 2 of the study was not initiated because there was no apparent relationship between raters, participant characteristics, and reliability ( Table 5 and eTables 3 and 4). The use of fi xed rater effects allows our results to be applied to the disciplines we used, but not to other disciplines. Second, because pADE cost was determined by discrepancies avoided, the cost savings that occurred because of RPh involvement unrelated to medications were not reported. One example was the identifi cation of an incorrect weight (computer entry of 196 kg rather than 196 lbs) discovered by the RPh on participant interview. During hospitalization, the participant had medication orders for heparin using a weight-based nomogram and subsequently enoxaparin was dosed at 1 mg/kg, thus the weight clarification avoided a potential bleeding event. Bleeding prevention cost savings has been reported as $6,702 per event prevented. 48 Third, a larger sample size may have been able to identify how to properly assign a specifi c health care discipline to a participant based upon admission characteristics. Last, future studies should consider a triage approach for conducting medication histories at admission with identical access to medication information for all disciplines, as well as conducting a sensitivity analysis for pADE-related cost savings.
CONCLUSIONS
This study used a novel method to evaluate discrepancies by discipline. RPhs committed fewer discrepancies than RNs and CPhTs, resulting in more accurate medication histories and reconciliation, particularly when detecting omitted and incorrect medications. RPh involvement in medication history and reconciliation prevented the greatest number of medication errors, leading to substantial pADE-related cost savings.
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